[Adjuvant chemotherapy of osteosarcoma]. 1990

S Yamawaki, and K Isu, and Y Ubayama, and N Takeda, and T Yagi, and M Usui, and S Isii
Dept of Orthop, National Sapporo Hospital Hokkaido Cancer Center.

Osteosarcoma is the one of the tumors that's prognosis have been improved dramatically by the introduction of chemotherapy consisting mainly of adriamycin, high-dose methotrexate with Leucovorin rescue and cisplatinum. Now, the purpose of the treatment for osteosarcoma are assurance of their life and functional and beautiful limb-sparing. Recently, preoperative chemotherapy for limb saving is given to patients with osteosarcoma of the extremities. The five year survival rate increased to 65% and limb sparing rate became above 50%. It is generally accepted that pre- and post-operative chemotherapy can inhibit pulmonary micro metastasis and prove to be of great significance in improving the survival rate of patients with osteosarcoma of extremities and achieve limb salvage operation.

UI MeSH Term Description Entries
D008297 Male Males
D008727 Methotrexate An antineoplastic antimetabolite with immunosuppressant properties. It is an inhibitor of TETRAHYDROFOLATE DEHYDROGENASE and prevents the formation of tetrahydrofolate, necessary for synthesis of thymidylate, an essential component of DNA. Amethopterin,Methotrexate Hydrate,Methotrexate Sodium,Methotrexate, (D)-Isomer,Methotrexate, (DL)-Isomer,Methotrexate, Dicesium Salt,Methotrexate, Disodium Salt,Methotrexate, Sodium Salt,Mexate,Dicesium Salt Methotrexate,Hydrate, Methotrexate,Sodium, Methotrexate
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D001859 Bone Neoplasms Tumors or cancer located in bone tissue or specific BONES. Bone Cancer,Cancer of Bone,Cancer of the Bone,Neoplasms, Bone,Bone Neoplasm,Neoplasm, Bone
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002945 Cisplatin An inorganic and water-soluble platinum complex. After undergoing hydrolysis, it reacts with DNA to produce both intra and interstrand crosslinks. These crosslinks appear to impair replication and transcription of DNA. The cytotoxicity of cisplatin correlates with cellular arrest in the G2 phase of the cell cycle. Platinum Diamminodichloride,cis-Diamminedichloroplatinum(II),cis-Dichlorodiammineplatinum(II),Biocisplatinum,Dichlorodiammineplatinum,NSC-119875,Platidiam,Platino,Platinol,cis-Diamminedichloroplatinum,cis-Platinum,Diamminodichloride, Platinum,cis Diamminedichloroplatinum,cis Platinum
D003131 Combined Modality Therapy The treatment of a disease or condition by several different means simultaneously or sequentially. Chemoimmunotherapy, RADIOIMMUNOTHERAPY, chemoradiotherapy, cryochemotherapy, and SALVAGE THERAPY are seen most frequently, but their combinations with each other and surgery are also used. Multimodal Treatment,Therapy, Combined Modality,Combined Modality Therapies,Modality Therapies, Combined,Modality Therapy, Combined,Multimodal Treatments,Therapies, Combined Modality,Treatment, Multimodal,Treatments, Multimodal
D004317 Doxorubicin Antineoplastic antibiotic obtained from Streptomyces peucetius. It is a hydroxy derivative of DAUNORUBICIN. Adriamycin,Adriablastin,Adriablastine,Adriblastin,Adriblastina,Adriblastine,Adrimedac,DOXO-cell,Doxolem,Doxorubicin Hexal,Doxorubicin Hydrochloride,Doxorubicin NC,Doxorubicina Ferrer Farm,Doxorubicina Funk,Doxorubicina Tedec,Doxorubicine Baxter,Doxotec,Farmiblastina,Myocet,Onkodox,Ribodoxo,Rubex,Urokit Doxo-cell,DOXO cell,Hydrochloride, Doxorubicin,Urokit Doxo cell
D004334 Drug Administration Schedule Time schedule for administration of a drug in order to achieve optimum effectiveness and convenience. Administration Schedule, Drug,Administration Schedules, Drug,Drug Administration Schedules,Schedule, Drug Administration,Schedules, Drug Administration
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

S Yamawaki, and K Isu, and Y Ubayama, and N Takeda, and T Yagi, and M Usui, and S Isii
June 1987, Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
S Yamawaki, and K Isu, and Y Ubayama, and N Takeda, and T Yagi, and M Usui, and S Isii
August 1989, Seminars in oncology,
S Yamawaki, and K Isu, and Y Ubayama, and N Takeda, and T Yagi, and M Usui, and S Isii
July 1981, Annals of the Academy of Medicine, Singapore,
S Yamawaki, and K Isu, and Y Ubayama, and N Takeda, and T Yagi, and M Usui, and S Isii
April 1986, Gan to kagaku ryoho. Cancer & chemotherapy,
S Yamawaki, and K Isu, and Y Ubayama, and N Takeda, and T Yagi, and M Usui, and S Isii
January 2001, La Chirurgia degli organi di movimento,
S Yamawaki, and K Isu, and Y Ubayama, and N Takeda, and T Yagi, and M Usui, and S Isii
March 1980, International journal of cancer,
S Yamawaki, and K Isu, and Y Ubayama, and N Takeda, and T Yagi, and M Usui, and S Isii
August 1978, Zeitschrift fur Orthopadie und ihre Grenzgebiete,
S Yamawaki, and K Isu, and Y Ubayama, and N Takeda, and T Yagi, and M Usui, and S Isii
December 1981, The Surgical clinics of North America,
S Yamawaki, and K Isu, and Y Ubayama, and N Takeda, and T Yagi, and M Usui, and S Isii
September 1997, Lancet (London, England),
S Yamawaki, and K Isu, and Y Ubayama, and N Takeda, and T Yagi, and M Usui, and S Isii
January 1987, Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
Copied contents to your clipboard!